Skip to main content

4D Molecular Therapeutics

Emeryville, United States

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

$200.0M raised
Jun 2026
Post-IPO Debt

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about 4D Molecular Therapeutics

How much funding has 4D Molecular Therapeutics raised?
4D Molecular Therapeutics has raised $200.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in June 2026.
Who are 4D Molecular Therapeutics's investors?
4D Molecular Therapeutics's investors include Janus Henderson Investors, Perceptive Advisors, Mirae Asset, Hercules Capital, Casdin Capital.
Where is 4D Molecular Therapeutics headquartered?
4D Molecular Therapeutics is headquartered in Emeryville, United States.
What does 4D Molecular Therapeutics do?
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
What stage is 4D Molecular Therapeutics at?
4D Molecular Therapeutics is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"4D Molecular Therapeutics — Funding & Investors." VCBacked, June 29, 2026, https://www.vcbacked.co/company/4d-molecular-therapeutics-emeryville. Accessed July 6, 2026.
APA
VCBacked. (2026). 4D Molecular Therapeutics — Funding & Investors. Retrieved July 6, 2026, from https://www.vcbacked.co/company/4d-molecular-therapeutics-emeryville
Wikipedia (cite web)
{{cite web |title=4D Molecular Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/4d-molecular-therapeutics-emeryville |website=VCBacked |access-date=July 6, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .